000			03963nam a22004215i 4500
710	2		_aSpringerLink (Online service) _0http://id.loc.gov/authorities/names/no2005046756 _1http://viaf.org/viaf/148105729 _9106996
999			_c107971 _d107971 _x1
001			107971
003			DE-He213
005			20230102113328.0
006			a||||fo|||| 00| 0
007			cr nn 008mamaa
008			180315s2018 si | s |||| 0|eng d
020			_a9789811058912
024	7		_a10.1007/978-981-10-5891-2 _2doi
040			_bspa _dES-MaUEC
050		4	_aRG575.5 2018 EB
245	0	0	_aPreeclampsia : _bBasic, Genomic, and Clinical _cedited by Shigeru Saito.
264		1	_aSingapore _bSpringer Singapore : _bImprint: Springer _c2018.
300			_a1 recurso en línea ( VIII, 290 páginas 54 ilustraciones, 32 ilustraciones a color)
336			_2rdacontent _aTexto (visual) _btxt
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
347			_atext file _bPDF _2rda
490	1		_aComprehensive Gynecology and Obstetrics _x2364-1932
490			_aMedicine (Springer-11650)
505	0		_aPart 1 Risk factors for preeclampsia -- 1 Risk factors for preeclampsia- Part 2 Genetic background in preeclampsia- 2 Genetic background in preeclampsia -- Part 3 Pathological findings in preeclampsia- 3 Shallow trophoblast invasion and poor vascular remodeling -- Part 4 Pathophysiology of preeclampsia- 4 Immunological maladaptation -- 5 Glucose intolerance and insulin resistance -- 6 Placental adenosine signaling -- 7 Obesity and lipokine -- 8 Autophagy in preeclampsia. 9 Animal models in preeclampsia -- 10 The differencies between early onset and late onset preeclampsia -- Part 5 Predicton of preeclampsia- 11 sFlt-1/PlGF -- 12 Home blood pressure measurement -- 13 micro RNA -- Part 6 Therapy- 14 New therapies for preeclampsia -- 15 Statin therapy for preeclampsia -- 16 Prevension of stroke and eclampsia -- Part 7 The risk for cardiovascular event in preeclamtic cases- 17 The risk for cardiovascular event in preeclamtic cases.
520			_aThis volume is an excellent guide that comprehensively illustrates hypertensive disorders of pregnancy, especially preeclampsia, in both the basic and clinical aspects. Preeclampsia is a pregnancy-specific multi-organ disorder and a leading cause of maternal and neonatal mortality. The pathophysiology of pregnancy-specific disorders was long unknown, but recently many new findings have been reported from the point of view of pathophysiology. Furthermore, this complication of pregnancy, especially preeclampsia, is a potent risk factor for chronic conditions such as cardiovascular disease, diabetes mellitus, kidney disease, and hypertension. The book is composed of seven parts including genetic background, pathology,  pathophysiology, and the latest prediction and treatment of preeclampsia. Specific basic topics such as immunological maladaptation, placental adenosine signaling, and new prediction markers are also expounded by experts. Thus it benefits not only obstetricians, pediatricians, nephrologists, diabetologists, and cardiologists, but also immunologists, endocrinologists, geneticists, pathologists, biologists, and molecular biologists who are interested in the treatment of hypertension in pregnancy.
988			_aSpringer_Medicine_2018
650		7	_2embne _9669795 _aPreeclampsia
650		7	_2embne _9169061 _aEmbarazo _xComplicaciones
700	1		_aSaito, Shigeru _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt _1http://viaf.org/viaf/110986488 _9100407
776	0	8	_iPrinted edition: _z9789811058905
776	0	8	_iPrinted edition: _z9789811058929
776	0	8	_iPrinted edition: _z9789811338649
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-981-10-5891-2 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_aSI _b02/2019 _cm _dz _feng _ggw _h0 _ejf _zSI